Silvia Miramontes, Umair Khan, Erin L. Ferguson, Marina Sirota, M. Maria Glymour
{"title":"在美国国家队列中,胆固醇水平与14年期间记忆和记忆变化的关系。","authors":"Silvia Miramontes, Umair Khan, Erin L. Ferguson, Marina Sirota, M. Maria Glymour","doi":"10.1002/trc2.70021","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> INTRODUCTION</h3>\n \n <p>The impact of cholesterol on late-life cognition remains controversial. We investigated the association of high-density lipoprotein cholesterol (HDL-C) and non–HDL-C with memory in a nationally representative cohort.</p>\n </section>\n \n <section>\n \n <h3> METHODS</h3>\n \n <p>Health and Retirement Study (HRS) participants (<i>N</i> = 13,258) aged 50+ (mean age: 67.2 years) followed from 2006 to 2020 provided cholesterol measures every 4 years and cognitive assessments biennially. Linear mixed models predicted memory scores using both baseline and time-updated cholesterol values.</p>\n </section>\n \n <section>\n \n <h3> RESULTS</h3>\n \n <p>Higher baseline HDL-C (mean: 53.9 mg/dL) predicted better memory scores (<i>β</i>: 0.05, 95% confidence interval [CI]: 0.03 to 0.08), but not memory change. Baseline non–HDL-C (mean: 143 mg/dL) predicted poorer memory scores (<i>β</i>: −0.01, 95% CI: −0.02 to 0.00), but not memory change. Time-updated HDL-C predicted better memory (<i>β</i>: 0.02, 95% CI: 0.00 to 0.04), but non–HDL-C showed no such associations.</p>\n </section>\n \n <section>\n \n <h3> DISCUSSION</h3>\n \n <p>While higher peripheral HDL-C is linked to better memory, the small effect sizes and absence of associations of HDL-C and non–HD-CL with memory change suggests that peripheral cholesterol has a small effect on the variation of memory scores.</p>\n </section>\n \n <section>\n \n <h3> Highlights</h3>\n \n <div>\n <ul>\n \n <li>Higher HDL-C levels predict better memory scores but not memory change across 14 years of follow-up.</li>\n \n <li>Baseline higher LDL-C levels predict poorer memory scores across time, but not memory change.</li>\n \n <li>The small effects and absence of consistent association between cholesterol levels and memory change suggest that cholesterol plays a minor role in cognitive decline.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":53225,"journal":{"name":"Alzheimer''s and Dementia: Translational Research and Clinical Interventions","volume":"11 1","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11696025/pdf/","citationCount":"0","resultStr":"{\"title\":\"The association of cholesterol levels with memory and memory change over a 14-year period in a US national cohort\",\"authors\":\"Silvia Miramontes, Umair Khan, Erin L. Ferguson, Marina Sirota, M. Maria Glymour\",\"doi\":\"10.1002/trc2.70021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> INTRODUCTION</h3>\\n \\n <p>The impact of cholesterol on late-life cognition remains controversial. We investigated the association of high-density lipoprotein cholesterol (HDL-C) and non–HDL-C with memory in a nationally representative cohort.</p>\\n </section>\\n \\n <section>\\n \\n <h3> METHODS</h3>\\n \\n <p>Health and Retirement Study (HRS) participants (<i>N</i> = 13,258) aged 50+ (mean age: 67.2 years) followed from 2006 to 2020 provided cholesterol measures every 4 years and cognitive assessments biennially. Linear mixed models predicted memory scores using both baseline and time-updated cholesterol values.</p>\\n </section>\\n \\n <section>\\n \\n <h3> RESULTS</h3>\\n \\n <p>Higher baseline HDL-C (mean: 53.9 mg/dL) predicted better memory scores (<i>β</i>: 0.05, 95% confidence interval [CI]: 0.03 to 0.08), but not memory change. Baseline non–HDL-C (mean: 143 mg/dL) predicted poorer memory scores (<i>β</i>: −0.01, 95% CI: −0.02 to 0.00), but not memory change. Time-updated HDL-C predicted better memory (<i>β</i>: 0.02, 95% CI: 0.00 to 0.04), but non–HDL-C showed no such associations.</p>\\n </section>\\n \\n <section>\\n \\n <h3> DISCUSSION</h3>\\n \\n <p>While higher peripheral HDL-C is linked to better memory, the small effect sizes and absence of associations of HDL-C and non–HD-CL with memory change suggests that peripheral cholesterol has a small effect on the variation of memory scores.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Highlights</h3>\\n \\n <div>\\n <ul>\\n \\n <li>Higher HDL-C levels predict better memory scores but not memory change across 14 years of follow-up.</li>\\n \\n <li>Baseline higher LDL-C levels predict poorer memory scores across time, but not memory change.</li>\\n \\n <li>The small effects and absence of consistent association between cholesterol levels and memory change suggest that cholesterol plays a minor role in cognitive decline.</li>\\n </ul>\\n </div>\\n </section>\\n </div>\",\"PeriodicalId\":53225,\"journal\":{\"name\":\"Alzheimer''s and Dementia: Translational Research and Clinical Interventions\",\"volume\":\"11 1\",\"pages\":\"\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-01-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11696025/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alzheimer''s and Dementia: Translational Research and Clinical Interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/trc2.70021\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Translational Research and Clinical Interventions","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/trc2.70021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
The association of cholesterol levels with memory and memory change over a 14-year period in a US national cohort
INTRODUCTION
The impact of cholesterol on late-life cognition remains controversial. We investigated the association of high-density lipoprotein cholesterol (HDL-C) and non–HDL-C with memory in a nationally representative cohort.
METHODS
Health and Retirement Study (HRS) participants (N = 13,258) aged 50+ (mean age: 67.2 years) followed from 2006 to 2020 provided cholesterol measures every 4 years and cognitive assessments biennially. Linear mixed models predicted memory scores using both baseline and time-updated cholesterol values.
RESULTS
Higher baseline HDL-C (mean: 53.9 mg/dL) predicted better memory scores (β: 0.05, 95% confidence interval [CI]: 0.03 to 0.08), but not memory change. Baseline non–HDL-C (mean: 143 mg/dL) predicted poorer memory scores (β: −0.01, 95% CI: −0.02 to 0.00), but not memory change. Time-updated HDL-C predicted better memory (β: 0.02, 95% CI: 0.00 to 0.04), but non–HDL-C showed no such associations.
DISCUSSION
While higher peripheral HDL-C is linked to better memory, the small effect sizes and absence of associations of HDL-C and non–HD-CL with memory change suggests that peripheral cholesterol has a small effect on the variation of memory scores.
Highlights
Higher HDL-C levels predict better memory scores but not memory change across 14 years of follow-up.
Baseline higher LDL-C levels predict poorer memory scores across time, but not memory change.
The small effects and absence of consistent association between cholesterol levels and memory change suggest that cholesterol plays a minor role in cognitive decline.
期刊介绍:
Alzheimer''s & Dementia: Translational Research & Clinical Interventions (TRCI) is a peer-reviewed, open access,journal from the Alzheimer''s Association®. The journal seeks to bridge the full scope of explorations between basic research on drug discovery and clinical studies, validating putative therapies for aging-related chronic brain conditions that affect cognition, motor functions, and other behavioral or clinical symptoms associated with all forms dementia and Alzheimer''s disease. The journal will publish findings from diverse domains of research and disciplines to accelerate the conversion of abstract facts into practical knowledge: specifically, to translate what is learned at the bench into bedside applications. The journal seeks to publish articles that go beyond a singular emphasis on either basic drug discovery research or clinical research. Rather, an important theme of articles will be the linkages between and among the various discrete steps in the complex continuum of therapy development. For rapid communication among a multidisciplinary research audience involving the range of therapeutic interventions, TRCI will consider only original contributions that include feature length research articles, systematic reviews, meta-analyses, brief reports, narrative reviews, commentaries, letters, perspectives, and research news that would advance wide range of interventions to ameliorate symptoms or alter the progression of chronic neurocognitive disorders such as dementia and Alzheimer''s disease. The journal will publish on topics related to medicine, geriatrics, neuroscience, neurophysiology, neurology, psychiatry, clinical psychology, bioinformatics, pharmaco-genetics, regulatory issues, health economics, pharmacoeconomics, and public health policy as these apply to preclinical and clinical research on therapeutics.